November 9, 2016
Nicox: update on Latanoprostene bunod and AC-170
Nicox S.A., the international ophthalmic R&D company, has provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 8, 2016
BD launches first syringe designed for use with Humulin R U-500 insulin
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
November 8, 2016
GENFIT's revenue halves in Q3 2016
GENFIT has today announced its cash and cash equivalents as at September 30, 2016
November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
November 8, 2016
After $195 million in talc verdicts, J&J strives to change court
After a $67.5 million jury verdict against Johnson & Johnson…
November 8, 2016
DBV Technologies closes down phase II study of Viaskin Milk
DBV Technologies has completed the enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk
November 8, 2016
BRIEF: Advanced Oncotherpay appoints new broker
BRIEF: Advanced Oncotherpay appoints new broker
November 7, 2016
Testing investigational Zika vaccine candidate in humans
The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine
November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
November 7, 2016
Vertex's Phase 3 cystic fibrosis drug study shows improvement
Vertex Pharmaceuticals Incorporated today announced the results of a Phase 3 study of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis…